Analyst Ratings for PTC Therapeutics (PTCT)
PTCT Rating Summary
PTCT Price Target Summary
- Highest: $73.00 (Cantor Fitzgerald)
- Lowest: $17.00 (Citi)
- Average: $34.21
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$34.21 (+37%)
* Over Last 12-Mos
Rating Score: 3.6 / 10
Percentile Rank: 34%
Avg. $ Target:
$34.21 (+37%)
* Over Last 12-Mos
Rating Score: 3.6 / 10
Percentile Rank: 34%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2023 | Morgan Stanley | Jeffrey Hung | Downgrade | Underweight (Equalweight) |
28.00 (N/A) |
28.39 (24.97) |
-12.05% | Details |
| 12/8/2023 | Wells Fargo | N/A | New Coverage | Overweight (N/A) |
37.00 (N/A) |
25.87 (24.97) |
-3.48% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
